BusinessAdmin•Yahoo Finance RSS•4 hours ago
Jefferies Highlights Iovance Biotherapeutics' Amtagvi Drug Potential
Jefferies emphasizes the potential of Iovance Biotherapeutics' Amtagvi drug, suggesting it could impact the company's market standing and attract investor interest.
- • Jefferies has recently spotlighted Iovance Biotherapeutics, particularly its drug Amtagvi, which is gaining attention in the biopharmaceutical sector.
- • The firm believes that Amtagvi could play a significant role in treating certain cancers, potentially enhancing Iovance's market position.
- • Investors are encouraged to monitor developments related to Amtagvi, as it may influence Iovance's stock performance and overall business trajectory.
Source: Yahoo Finance RSS
Read original →
